Loading
SmartCardia
SmartCardia is a Swiss medical technology company founded in 2013, specializing in cardiology and remote patient monitoring. The company is headquartered at the EPFL Innovation Park in Lausanne, Switzerland, with a presence in the U.S. through SmartCardia, Inc. in Des Plaines, Illinois. SmartCardia aims to enhance cardiac care by integrating wearable technology with artificial intelligence, providing real-time insights into patient health. The company's flagship product is a 7-Lead ECG patch, a cable-free and skin-friendly device that can be worn for up to 14 days. It records multiple vital signs, including heart rate and blood oxygen levels, and has received FDA clearance and European CE Class IIa approval. SmartCardia also offers an AI-powered cloud platform, SmartNeuralNet, which streams ECG data for AI-assisted analysis, enabling healthcare professionals to monitor patients effectively. The company primarily serves hospitals and clinicians, focusing on remote patient monitoring for conditions such as heart failure and atrial fibrillation.
Funding
Every round, secondary, debt facility or acquisition involving SmartCardia that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—